Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
14.25
-1.28 (-8.26%)
Nov 21, 2025, 4:00 PM EST - Market closed
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $153.42 million as of November 21, 2025. Its market cap has increased by 428.46% in one year.
Market Cap
153.42M
Enterprise Value
92.91M
1-Year Change
428.46%
Ranking
Category
Stock Price
$14.25
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $153.42M, a decrease of -93.88%. That is a compound annual growth rate of -40.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 167.24M | 141.51% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 950.48B |
| Johnson & Johnson | 497.66B |
| AbbVie | 419.77B |
| UnitedHealth Group | 292.77B |
| AstraZeneca | 277.11B |
| Merck & Co. | 247.58B |
| Novartis AG | 239.24B |
| Abbott Laboratories | 222.84B |